- Report
- May 2023
- 110 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- October 2023
- 146 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- October 2023
- 146 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- March 2024
- 132 Pages
Global
From €900EUR$950USD£752GBP
- Report
- July 2024
- 216 Pages
Global
From €2516EUR$2,655USD£2,102GBP
- Report
- August 2022
- 329 Pages
Global
From €3497EUR$3,690USD£2,922GBP
The Immunofluorescence Assay (IFA) market is a segment of the In Vitro Diagnostics (IVD) industry. It is used to detect the presence of antigens or antibodies in a sample, such as a blood or tissue sample. This type of assay is used to diagnose a variety of diseases, including autoimmune diseases, infectious diseases, and cancer. It is a highly sensitive and specific method of diagnosis, and is often used in combination with other diagnostic tests.
IFA tests are typically performed in a laboratory setting, and require specialized equipment and reagents. The market is driven by the increasing prevalence of diseases, the growing demand for accurate and timely diagnosis, and the development of new technologies.
Some of the major players in the Immunofluorescence Assay market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, and Roche Diagnostics. Show Less Read more